OBJECTIVE: To examine the association between alcohol consumption and markers of inflammation in preclinical rheumatoid arthritis (RA). METHODS: We studied 174 incident RA cases with stored blood collected 1-16 years prior to RA symptoms (preclinical RA), from the Nurses' Health Study. Alcohol intake was measured using a detailed food frequency questionnaire administered every 4 years, prior to blood collection. Plasma was tested for biomarkers of inflammation, including high-sensitivity C-reactive protein (hsCRP), anti-cyclic citrullinated peptide (anti-CCP) antibodies, interleukin-6 (IL-6), and soluble tumor necrosis factor receptor II (sTNFRII). Generalized additive models were used to identify structure in the relationship between each biomarker and cumulative average alcohol intake. Then general linear models were used for multivariable adjusted analyses with appropriate polynomial terms of alcohol consumption. RESULTS: After controlling for age at blood collection, smoking, parity and duration of breastfeeding, menopausal status, oral contraceptive use, body mass index, and the time between blood collection and RA onset, we found that the daily alcohol consumption showed a U-shaped association with IL-6 levels in RA patients, prior to symptoms. We also found an inverse relationship between alcohol intake and sTNFRII levels, but no associations with hsCRP or anti-CCP levels. CONCLUSION: These results demonstrate an association between alcohol consumption and markers of inflammation, including IL-6 and sTNFRII, in RA patients, prior to the occurrence of symptoms.
OBJECTIVE: To examine the association between alcohol consumption and markers of inflammation in preclinical rheumatoid arthritis (RA). METHODS: We studied 174 incident RA cases with stored blood collected 1-16 years prior to RA symptoms (preclinical RA), from the Nurses' Health Study. Alcohol intake was measured using a detailed food frequency questionnaire administered every 4 years, prior to blood collection. Plasma was tested for biomarkers of inflammation, including high-sensitivity C-reactive protein (hsCRP), anti-cyclic citrullinated peptide (anti-CCP) antibodies, interleukin-6 (IL-6), and soluble tumor necrosis factor receptor II (sTNFRII). Generalized additive models were used to identify structure in the relationship between each biomarker and cumulative average alcohol intake. Then general linear models were used for multivariable adjusted analyses with appropriate polynomial terms of alcohol consumption. RESULTS: After controlling for age at blood collection, smoking, parity and duration of breastfeeding, menopausal status, oral contraceptive use, body mass index, and the time between blood collection and RA onset, we found that the daily alcohol consumption showed a U-shaped association with IL-6 levels in RA patients, prior to symptoms. We also found an inverse relationship between alcohol intake and sTNFRII levels, but no associations with hsCRP or anti-CCP levels. CONCLUSION: These results demonstrate an association between alcohol consumption and markers of inflammation, including IL-6 and sTNFRII, in RA patients, prior to the occurrence of symptoms.
Authors: Ing-Marie Jonsson; Margareta Verdrengh; Mikael Brisslert; Sofia Lindblad; Maria Bokarewa; Ulrika Islander; Hans Carlsten; Claes Ohlsson; Kutty Selva Nandakumar; Rikard Holmdahl; Andrej Tarkowski Journal: Proc Natl Acad Sci U S A Date: 2006-12-21 Impact factor: 11.205
Authors: Jennifer K Pai; Susan E Hankinson; Ravi Thadhani; Nader Rifai; Tobias Pischon; Eric B Rimm Journal: Atherosclerosis Date: 2005-08-01 Impact factor: 5.162
Authors: H Källberg; S Jacobsen; C Bengtsson; M Pedersen; L Padyukov; P Garred; M Frisch; E W Karlson; L Klareskog; L Alfredsson Journal: Ann Rheum Dis Date: 2008-06-05 Impact factor: 19.103
Authors: Lori B Chibnik; Lisa A Mandl; Karen H Costenbader; Peter H Schur; Elizabeth W Karlson Journal: J Rheumatol Date: 2009-02-17 Impact factor: 4.666
Authors: Elizabeth W Karlson; Lori B Chibnik; Shelley S Tworoger; I-Min Lee; Julie E Buring; Nancy A Shadick; Joann E Manson; Karen H Costenbader Journal: Arthritis Rheum Date: 2009-03
Authors: Merete Pedersen; Søren Jacobsen; Mette Klarlund; Bo V Pedersen; Allan Wiik; Jan Wohlfahrt; Morten Frisch Journal: Arthritis Res Ther Date: 2006 Impact factor: 5.156
Authors: Joline W J Beulens; Eric B Rimm; Frank B Hu; Henk F J Hendriks; Kenneth J Mukamal Journal: Diabetes Care Date: 2008-07-15 Impact factor: 19.112
Authors: Medha Barbhaiya; Bing Lu; Jeffrey A Sparks; Susan Malspeis; Shun-Chiao Chang; Elizabeth W Karlson; Karen H Costenbader Journal: Arthritis Care Res (Hoboken) Date: 2017-03 Impact factor: 4.794
Authors: Joshua F Baker; Bryant R England; Ted R Mikuls; Jesse Y Hsu; Michael D George; Sofia Pedro; Harlan Sayles; Kaleb Michaud Journal: Arthritis Care Res (Hoboken) Date: 2020-02-12 Impact factor: 4.794
Authors: Bing Lu; Young Hee Rho; Jing Cui; Christine K Iannaccone; Michelle L Frits; Elizabeth W Karlson; Nancy A Shadick Journal: J Rheumatol Date: 2013-12-01 Impact factor: 4.666
Authors: Marshall L R Davis; Kaleb Michaud; Harlan Sayles; Doyt L Conn; Larry W Moreland; S Louis Bridges; Ted R Mikuls Journal: J Rheumatol Date: 2013-06-15 Impact factor: 4.666